Long-Term Pancreatic Functional Impairment After Surgery for Neuroendocrine Neoplasms

Overview

Journal J Clin Med

Specialty General Medicine

Date 2019 Oct 19

PMID 31623399

Citations 5

Authors

Valentina Andreasi

Stefano Partelli

Gabriele Capurso

Francesca Muffatti

Gianpaolo Balzano

Stefano Crippa

Massimo Falconi

Affiliations

Soon will be listed here.

Abstract

Radical surgery represents the only curative treatment for pancreatic neuroendocrine neoplasms (PanNEN). The aim of this study was to evaluate the postoperative onset of diabetes mellitus (DM) and/or pancreatic exocrine insufficiency (PEI) in surgically treated PanNEN. Consecutive PanNEN patients, without preoperative DM, who underwent partial pancreatic resection, were included. After a median follow-up of 72 months, overall 68/276 patients (24%) developed DM. Patients who developed DM were significantly older ( = 0.002) and they had a higher body mass index (BMI) ( < 0.0001) than those who did not; they were more frequently male ( = 0.017) and with nonfunctioning neoplasms ( = 0.019). BMI > 25 Kg/m was the only independent predictor of DM ( = 0.001). Overall, 118/276 patients (43%) developed a PEI, which was significantly more frequent after pancreaticoduodenectomy ( < 0.0001) and in patients with T3-T4 tumors ( = 0.001). Pancreaticoduodenectomy was the only independent predictor of PEI ( < 0.0001). Overall, 54 patients (20%) developed disease progression. Patients with and without DM had similar progression free survival (PFS), whereas patients without PEI had better five-year-PFS ( = 0.002), although this association was not confirmed in multivariate analysis. The risk of DM and PEI after surgery for PanNEN is relatively high but it does not affect PFS. BMI and pancreatic head resection are independent predictors of DM and PEI, respectively.

Citing Articles

Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours.

Partelli S, Battistella A, Andreasi V, Muffatti F, Tamburrino D, Pecorelli N BJS Open. 2024; 8(4).

PMID: 39107074 PMC: 11303005. DOI: 10.1093/bjsopen/zrae083.

Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors-a Systematic Review and Meta-analysis of Surgery-Associated Morbidity.

Beger H, Mayer B, Poch B J Gastrointest Surg. 2023; 27(11):2611-2627.

PMID: 37670106 PMC: 10661729. DOI: 10.1007/s11605-023-05789-4.

Parenchymal Sparing Resection: Options in Duodenal and Pancreatic Surgery.

Marchese U, Tzedakis S, Ali E, Turrini O, Delpero J, Coriat R J Clin Med. 2021; 10(7).

PMID: 33918376 PMC: 8038287. DOI: 10.3390/jcm10071479.

Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.

Liu X, Chin W, Pan C, Zhang W, Yu J, Zheng S Gland Surg. 2021; 10(1):219-232.

PMID: 33633978 PMC: 7882341. DOI: 10.21037/gs-20-582.

Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors.

Pusceddu S, Rossi R, Torchio M, Prinzi N, Niger M, Coppa J J Clin Med. 2020; 9(8).

PMID: 32752158 PMC: 7464810. DOI: 10.3390/jcm9082468.

References

Lim P, Dinh K, Sullivan M, Wassef W, Zivny J, Whalen G . Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB (Oxford). 2016; 18(4):360-6. PMC: 4814621. DOI: 10.1016/j.hpb.2015.11.003. View

Gaujoux S, Partelli S, Maire F, DOnofrio M, Larroque B, Tamburrino D . Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2013; 98(12):4784-9. DOI: 10.1210/jc.2013-2604. View

Falconi M, Eriksson B, Kaltsas G, Bartsch D, Capdevila J, Caplin M . ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016; 103(2):153-71. PMC: 4849884. DOI: 10.1159/000443171. View

Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M . The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017; 161(3):584-591. DOI: 10.1016/j.surg.2016.11.014. View

Mann S, Stracke H, Lange U, Klor H, Teichmann J . Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas. Dig Dis Sci. 2003; 48(3):533-8. DOI: 10.1023/a:1022540816990. View

Santangelo M, Esposito A, Tammaro V, Calogero A, Criscitiello C, Roberti G . What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review. Int J Surg. 2015; 28 Suppl 1:S172-6. DOI: 10.1016/j.ijsu.2015.12.046. View

You D, Choi S, Choi D, Heo J, Ho C, Kim W . Long-term effects of pancreaticoduodenectomy on glucose metabolism. ANZ J Surg. 2012; 82(6):447-51. DOI: 10.1111/j.1445-2197.2012.06080.x. View

Hirata K, Nakata B, Amano R, Yamazoe S, Kimura K, Hirakawa K . Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients. J Gastrointest Surg. 2014; 18(9):1597-603. DOI: 10.1007/s11605-014-2521-5. View

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y . Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342. PMC: 5824320. DOI: 10.1001/jamaoncol.2017.0589. View

10.

Alfieri S, Agnes A, Rosa F, Di Miceli D, Grieco D, Scaldaferri F . Long-term pancreatic exocrine and endometabolic functionality after pancreaticoduodenectomy. Comparison between pancreaticojejunostomy and pancreatic duct occlusion with fibrin glue. Eur Rev Med Pharmacol Sci. 2018; 22(13):4310-4318. DOI: 10.26355/eurrev_201807_15427. View

11.

Shirakawa S, Matsumoto I, Toyama H, Shinzeki M, Ajiki T, Fukumoto T . Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012; 16(12):2212-9. PMC: 3508270. DOI: 10.1007/s11605-012-2039-7. View

12.

Winny M, Paroglou V, Bektas H, Kaltenborn A, Reichert B, Zachau L . Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis. Surgery. 2013; 155(2):271-9. DOI: 10.1016/j.surg.2013.08.012. View

13.

Tran T, van Lanschot J, Bruno M, van Eijck C . Functional changes after pancreatoduodenectomy: diagnosis and treatment. Pancreatology. 2010; 9(6):729-37. DOI: 10.1159/000264638. View

14.

Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P . Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2007; 95(1):85-91. DOI: 10.1002/bjs.5652. View

15.

Crippa S, Bassi C, Salvia R, Falconi M, Butturini G, Pederzoli P . Enucleation of pancreatic neoplasms. Br J Surg. 2007; 94(10):1254-9. DOI: 10.1002/bjs.5833. View

16.

Cauley C, Pitt H, Ziegler K, Nakeeb A, Schmidt C, Zyromski N . Pancreatic enucleation: improved outcomes compared to resection. J Gastrointest Surg. 2012; 16(7):1347-53. DOI: 10.1007/s11605-012-1893-7. View

17.

Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P . Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011; 150(1):75-82. DOI: 10.1016/j.surg.2011.02.022. View

18.

Benini L, Gabbrielli A, Cristofori C, Amodio A, Butturini G, Cardobi N . Residual pancreatic function after pancreaticoduodenectomy is better preserved with pancreaticojejunostomy than pancreaticogastrostomy: A long-term analysis. Pancreatology. 2019; 19(4):595-601. DOI: 10.1016/j.pan.2019.04.004. View

19.

Genc C, Jilesen A, Partelli S, Falconi M, Muffatti F, van Kemenade F . A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors. Ann Surg. 2017; 267(6):1148-1154. DOI: 10.1097/SLA.0000000000002123. View

20.

Gharios J, Hain E, Dohan A, Prat F, Terris B, Bertherat J . Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas. Best Pract Res Clin Endocrinol Metab. 2019; 33(5):101294. DOI: 10.1016/j.beem.2019.101294. View